SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$42.30
-1.36 (-3.12%)
Financial Highlights (FY 2025)
Revenue
910.50M
Net Income
-11,497,538
Gross Margin
56.3%
Profit Margin
-1.3%
Rev Growth
+11.0%
D/E Ratio
0.75
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 56.3% | 56.3% | 56.3% |
| Operating Margin | -1.1% | -1.1% | -1.0% |
| Profit Margin | -1.3% | -1.4% | -1.4% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Gross Profit | 512.72M | 495.99M | 476.78M |
| Operating Income | -10,289,963 | -9,855,064 | -8,493,684 |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Gross Margin | 56.3% | 56.3% | 56.3% |
| Operating Margin | -1.1% | -1.1% | -1.0% |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| Rev Growth | +11.0% | +3.4% | +15.4% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 2.14B | 2.25B | 2.41B |
| Total Equity | 2.86B | 2.71B | 3.09B |
| D/E Ratio | 0.75 | 0.83 | 0.78 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |